EUVIMEDEUVIMED entdecken
Open Access

HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion

Jenny C Pessa iD, Oona Paavolainen iD, Hendrik S E Hästbacka iD, Mikael C Puustinen iD, Alejandro J Da Silva iD, Sandra Pihlström iD, Silvia Gramolelli, Pia Boström iD, Pauliina Hartiala iD, Emilia Peuhu iD, Jenny Joutsen iD, Lea Sistonen iD

Science Advances · 2025

DOI: 10.1126/sciadv.ady1289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Jenny C Pessa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland. Hauptthemen laut MEDLINE: Breast Neoplasms, Heat-Shock Proteins, Carcinoma, Intraductal, Noninfiltrating, Transcription Factors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is hallmarked by phenotypic transitions enabling abnormal cell proliferation and invasion. The stress-protective transcription factor heat shock factor 2 (HSF2) is associated with cancer, but its function in breast carcinogenesis remains poorly understood. Analysis of human breast tumor samples and mouse in vivo xenografts uncovered that HSF2 expression and activity undergo dynamic changes as a function of tumor progression. HSF2 expression, nuclear localization, and coexpression with the proliferation marker Ki67 are increased in ductal carcinoma in situ (DCIS), suggesting that HSF2 designates hyperplastic cells underlying tumor expansion. In mouse xenografts, HSF2 localization switches from nuclear to cytoplasmic upon DCIS-to-invasive transition. Using cell-based models, we identify canonical transforming growth factor–β (TGF-β) signaling as the molecular mechanism regulating HSF2. TGF-β–mediated down-regulation of HSF2 allowed acquisition of an invasive cell phenotype, which was counteracted by ectopic HSF2. Together, we propose that HSF2 acts as a stage-specific switch between proliferation and invasion in breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHeat-Shock ProteinsCarcinoma, Intraductal, NoninfiltratingTranscription FactorsHumansFemaleCell ProliferationAnimalsMiceHeat Shock Transcription FactorsDisease ProgressionNeoplasm InvasivenessTransforming Growth Factor betaCell Line, TumorGene Expression Regulation, NeoplasticSignal Transduction

Substanzen

Heat Shock Transcription FactorsTransforming Growth Factor betaHSF2 protein, humanHeat-Shock ProteinsTranscription Factors

Autor:innen und Institutionen

  • Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
  • Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Institute of Biomedicine, University of Turku, Turku, Finland.
  • Western Finnish Cancer Center (FICAN West), University of Turku and Turku University Hospital, Turku, Finland.
  • InFLAMES Research Flagship Center, University of Turku and Åbo Akademi University, Turku, Finland.
  • University of Turku and Turku University Hospital, Turku, Finland.

ORCID-Profile: Jenny C Pessa, Oona Paavolainen, Hendrik S E Hästbacka, Mikael C Puustinen, Alejandro J Da Silva, Sandra Pihlström, Pia Boström, Pauliina Hartiala, Emilia Peuhu, Jenny Joutsen, Lea Sistonen

Zitieren

APA

Pessa, J. C., Paavolainen, O., Hästbacka, H. S. E., Puustinen, M. C., Da Silva, A. J., Pihlström, S., Gramolelli, S., Boström, P., Hartiala, P., Peuhu, E., Joutsen, J., & Sistonen, L. (2025). HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion. Science Advances. https://doi.org/10.1126/sciadv.ady1289

Vancouver

Pessa JC, Paavolainen O, Hästbacka HSE, Puustinen MC, Da Silva AJ, Pihlström S, et al. HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion. Science Advances. 2025. doi:10.1126/sciadv.ady1289

BibTeX
@article{Pessa2025,
  author = {Pessa, Jenny C and Paavolainen, Oona and Hästbacka, Hendrik S E and Puustinen, Mikael C and Da Silva, Alejandro J and Pihlström, Sandra and Gramolelli, Silvia and Boström, Pia and Hartiala, Pauliina and Peuhu, Emilia and Joutsen, Jenny and Sistonen, Lea},
  title = {HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.ady1289}
}
Kostenlos starten →